These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2435196)

  • 1. The clinical scope of disopyramide seven years after introduction--an overview.
    Willis PW
    Angiology; 1987 Feb; 38(2 Pt 2):165-73. PubMed ID: 2435196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of propafenon and disopyramide in ventricular extrasystole. Comparative study].
    Kenedi P
    MMW Munch Med Wochenschr; 1982 Aug; 124(34):734-6. PubMed ID: 6182460
    [No Abstract]   [Full Text] [Related]  

  • 5. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
    Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
    Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
    Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D
    G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disopyramide.
    Koch-Weser J
    N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical treatment of extrasystole and tachycardia (author's transl)].
    Theisen K; Jahrmärker H
    MMW Munch Med Wochenschr; 1980 Jan; 122(3):87-94. PubMed ID: 6154235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the effects of disopyramide phosphate on left ventricular function and the peripheral circulation.
    Di Bianco R; Gottdiener JS; Singh SN; Fletcher RD
    Angiology; 1987 Feb; 38(2 Pt 2):174-83. PubMed ID: 3103491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Piot O; Flammang D; Dambrine P; Cheikel J; Jouannon C; Graux P; Baudouy Y; Bine-Scheck F; Leenhardt A
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
    Abdalla A; Mazur NA; Nazarenko VA
    Kardiologiia; 1991 Jun; 31(6):22-5. PubMed ID: 1717733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C; Medvedowsky JL; Clémenty J; Bricaud H; Pellet J; Denis B; Machecourt J; Wolf JE; Dimitrio R; Egre A
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
    Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of Norpace (Part VII).
    Berman R
    Angiology; 1975 Jan; 26(1 Pt 2):143. PubMed ID: 1090214
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical scope of disopyramide. A clinical symposium. San Antonio, Texas, November 5, 1984. Proceedings.
    Angiology; 1987 Feb; 38(2 Pt 2):165-204. PubMed ID: 3103490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
    Shpektor AV; Gorshkov VA; Mamaev VI; Sherashov VS; Kurakina TI
    Sov Med; 1986; (12):96-7. PubMed ID: 2436318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.